Low-dose rituximab every 6 months for the treatment of acetylcholine receptor-positive refractory generalized myasthenia gravis.
Jun LuHuahua ZhongSisi JingLiang WangJianying XiJiahong LuLei ZhouChong-Bo ZhaoPublished in: Muscle & nerve (2020)
Low-dose rituximab every 6 months is effective in treating refractory GMG patients.